top of page

Iowa Asks DEA To Guarantee Protections For Medical Marijuana Program After Facing Activist Lawsuit

  • Writer: Bob Marley
    Bob Marley
  • May 4, 2021
  • 3 min read

Iowa officials are requesting that federal agencies guarantee they won’t punish people for participating in the state’s medical marijuana program, avoiding a protracted legal challenge in the process.

Last year, the legislature approved a bill that required the state to seek the protections for its medical cannabis program from the Drug Enforcement Administration (DEA). After months of inaction, activist Carl Olsen filed suit against the governor, alleging that she failed to ensure that the law was effectively carried out because the Department of Public Health had unnecessarily delayed the mandated request.

But within weeks of that lawsuit being filed, the state department on April 23 sent letters to DEA, the Food and Drug Administration, the Centers for Medicare and Medicaid Services and the Department of Education seeking a policy carve-out for Iowa’s limited medical cannabis market.

In the letters, the department simply quoted the statute of the law and said it “respectfully requests the guarantee as directed by the Iowa General Assembly.”

Here’s the relevant text of the statute: 

“The department of public health shall request guarantees from the agencies of the federal government providing funding to educational and long-term care facilities that facilities with policies allowing patients to possess medical cannabidiol on the grounds of the facilities consistent with chapter 124E or allowing facility staff to administer medical cannabidiol to a patient shall not lose eligibility for any federal funding due to such policies.”

After being informed via a court filing that the department had made good on its obligation, Olsen agreed that the lawsuit was no longer relevant. However, he had sharp words for the government over its handling of the matter, namely its decision to send a short letter rather than file a formal application for federal exemption.

“All Iowa citizens are directly injured by the apparent inconsistency with federal drug law, which throws people with serious disabilities under the bus while endangering the general public,” the long-time activist said. “The department knows a better solution and it said so on September 4, 2020.”

“It’s a sad day when state government chooses to ignore federal law rather than comply with it,” he continued in his response to the state’s motion to dismiss. “What a horrible example of scofflaw and disorder. The people of Iowa deserve better.”

Regulators said in a report last year that the department would “move forward with seeking an exception for cannabis as a schedule I substance in Iowa from the DEA, in attempt to minimize conflict between State and Federal Law.” But until last week, it had declined to act beyond saying in February that it was “still evaluating the best way to proceed.”

Last year, DEA rejected a request for an exemption that was submitted by Olsen himself, but he has been hopeful that the result would be different with the state formally involved.

DEA regulations stipulate that the agency’s administrator “may grant an exemption in his discretion, but in no case shall he/she be required to grant an exception to any person which is otherwise required by law or the regulations.”

On a related note, the Hawaii legislature recently adopted a resolution seeking an exemption from DEA stipulating that the state is permitted to run its medical cannabis program without federal interference. While the House approved an identical measure last month, it only applied to that chamber. This separate concurrent version cleared the House first before being adopted in final form by the Senate last month.

Read the state and Olsen’s most recent court filings below:

Iowa Motion to Dismiss and … by Marijuana Moment

Louisiana House Votes To Legalize Medical Marijuana Flower And Advances Bill To Prepare For Recreational Legalization

Photo courtesy of Kimberly Lawson.

Comments


Global SEO Keywords

marihuana, cannabis, cáñamo, CBD, aceite de CBD, bálsamo de CBD, marijuana, hemp, weed, CBD oil, CBD balm, canapa, erba, olio di CBD, balsamo CBD, chanvre, herbe, huile de CBD, baume CBD, Marihuana, Cannabis, Hanf, Gras, CBD Öl, CBD Balsam, maconha, cânhamo, erva, óleo de CBD, bálsamo CBD, hennep, wiet, CBD olie, CBD balsem, hampa, gräs, CBD olja, CBD balsam, hamp, græs, gress, CBD olje, hamppu, ruoho, CBD öljy, CBD balsami, konopie, konopie indyjskie, olej CBD, balsam CBD, konopí, CBD olej, CBD balzám, konope, CBD balzam, marihuána, kannabisz, kender, fű, CBD olaj, CBD balzsam, canabis, cânepă, iarbă, ulei CBD, марихуана, канабис, коноп, CBD масло, CBD балсам, μαριχουάνα, κάνναβη, χασίς, λάδι CBD, βάλσαμο CBD, kanabis, konoplja, trava, CBD ulje, CBD olje, kanapės, kanapės indinės, CBD aliejus, CBD balzamas, marihuāna, kaņepes, CBD eļļa, CBD balzams, marihuaana, kanep, CBD õli, CBD palsam, kannabis, qanneb, żejt CBD, balsam CBD, marijúna, hampur, CBD olía, CBD smyrsl

Disclaimer

Jacob Hooy CBD Lip Balm is free from parabens and artificial colorants and contains no toxins or heavy metals, supporting natural body care. Our products are not intended to diagnose, treat, cure, or prevent any disease, medical condition, or symptom. The information provided on this website is for informational purposes only and must not be considered medical advice, nor a substitute for professional diagnosis, treatment, or guidance provided by qualified physicians, healthcare professionals, or pharmaceutical specialists. Nothing on this website should be interpreted as a recommendation, prescription, or therapeutic claim.

Difresh Spain is an online retail store registered under IAE Group 652.3, specializing in the retail trade of perfumery, cosmetic products, and personal hygiene and care items. NIF: Y3526859-F. E-mail: info@cbdvending.eu - WhatsApp: +34662918154 - Factory adress: Calle Albardín 13, Nave B07, 50720, La cartuja baja, Zaragoza, España. All prices include VAT and free shipping across all European Union countries.

© 2026 - www.cbdvending.euPrivacy Policy

bottom of page